We have largely been saying that for the past 3 years. Every deal leaves us waiting for the next deal because of the promise of up fronts. We need sales from deals...something we still seem to be struggling with.
Wven with Amgen deal...unless there is some mechanism for sales in the med term how will it be any differe to the Sanofi and other deals which ultimatley were not supported by any indication of device sales and revenue? Rather just more qtrs of cash burn and losses whilst we wait 3+ years for perhaps commercial sales
- Forums
- ASX - By Stock
- UNS
- Shorters
Shorters, page-22
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)